Search results for: 'ai global'

As artificial intelligence (AI) moves from experimentation to enterprise deployment, growth is no longer limited by access to models. It is increasingly shaped by how well organizations can scale, govern, and monetize AI in real operating environments. The AI technologies and platforms market is entering a phase where economics, trust, regulation, ...

11 Sep 2026  |  Global  |  Market Research

Growth Impact of AI on the Communication Test Equipment Market, 2025–2030

Use of AI for Diagnostics and Predictive Analytics is Driving Transformational Growth

Infographics

×

Artificial intelligence (AI) is reshaping the global communication test equipment market by transforming product development, enabling intelligent and automated testing, and driving demand through next-generation communication infrastructure. This Frost & Sullivan analysis examines AI's impact across the communication test equipment value chain, fr...

Industrial manufacturing faces unprecedented disruption from equipment downtime, skills shortages, and volatile trade policies, while legacy systems struggle to integrate with modern AI. Fortune 500 companies lose significant revenue each year to unplanned downtime. At the same time, manufacturers face margin compression from tariff volatility and ...

As generative AI becomes deeply embedded in enterprise operations, fueling copilots, assistants, and automated agents, organizations face a wave of new and dynamic security risks. Traditional cybersecurity architectures are ill-equipped to address the fluidity, autonomy, and unpredictability of GenAI systems. This report provides chief information ...

09 Sep 2024  |  Global  |  Technology Research

AI-based Drug Repurposing Market, Growth Opportunities, Global, 2024-2029

AI-based Drug Repurposing is emerging as a new and faster approach to bringing drugs to patients.

Infographics

×

This study analyzes the emergence of AI-based drug repurposing and examines the factors driving and hindering adoption. The limitation of traditional drug discovery has led to the growing interest in AI -based drug repurposing, which offers numerous advantages in terms of time, speed, and cost. AI-based drug repurposing has been explored across dif...

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion models, and structure-based models are expanding the u...

AI has been embedded in telecommunications for over a decade, initially through rule-based automation and early machine learning applied to network optimization, fraud detection, and customer analytics. Even before 5G, CSPs used AI to enable self-optimizing networks (SON), predictive maintenance, and customer experience management—leveraging large ...

The application of Generative AI (Gen AI) in healthcare is a rapidly growing field. In recent years, emerging applications in drug discovery and development, medical imaging analysis, digital twins, synthetic data, and electronic health records management, and virtual assistants have garnered significant interest thanks to their potential to revolu...

In an evolving digital landscape, artificial intelligence (AI) is emerging as a preeminent force poised to reshape traditional job functions, operational processes, and business models. Cross-industry enterprises embrace innovative multimodal AI tools, solutions, and platforms to augment business growth, optimize operations, create strategic differ...